UPDATE 1-Samsung Bioepis plans Nasdaq listing by end-June

* High valuation could see IPO yield up to $1.7 bln -spokesman (Adds company comment, Samsung group leadership transfer context, analyst comment)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.